Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Charmaine Gittleson purchased 1,666,666 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The stock was bought at an average cost of A$0.01 ($0.01) per share, for a total transaction of A$14,999.99 ($9,316.77).
Percheron Therapeutics Stock Performance
About Percheron Therapeutics
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
See Also
- Five stocks we like better than Percheron Therapeutics
- The Most Important Warren Buffett Stock for Investors: His Own
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Nebius Group: The Rising Star in AI Infrastructure
- Industrial Products Stocks Investing
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
